Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*

By  

Oncology Research and Treatment, Vol. 30, Iss. 4, 2007-03 ,pp. : 185-191

Karger

Access to resources Recommend Favorite

Pharmacokinetic and biodistribution studies of Amphotericin B microspheres

By Angra Pawan K.   Siddig Aladin   Nettey Henry   Desai Nishil   Oettinger Carl   D'Souza Martin J.  

Journal of Microencapsulation, Vol. 26, Iss. 7, 2009-11 ,pp. : 627-634

Informa Healthcare

Access to resources Recommend Favorite

Cost-Benefit Assessment of Antifungal Prophylaxis with Liposomal Amphotericin B in Neutropenic Patients

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 621-626

Karger

Access to resources Recommend Favorite

Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children

By Sunakawa Keisuke  

Journal of Infection and Chemotherapy, Vol. 18, Iss. 4, 2012-08 ,pp. : 456-465

Springer Publishing Company

Access to resources Recommend Favorite

Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden

By Naik Shalini   Lundberg Johan   Kumar Ritesh   Sjolin Jan   Jansen Jeroen P.  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 6-7, 2011-07 ,pp. : 504-514

Informa Healthcare

Access to resources Recommend Favorite